Wize Pharma, Inc. company info

CIK 1218683
IRS Number 880445167
State of incorporation DE
Business address 24 HANAGAR ST
None
HOD HASHARON
L3
4527713
Mail address 24 HANAGAR ST
None
HOD HASHARON
L3
4527713

Short summary

Wize Pharma, Inc. is a Israel company, with head office located at 24 Hanagar St Hod Hasharon, Israel 4527713. In 2018 the company owned a total of 2.60 million USD worth of assets, including 2.54 million USD worth of current assets and 58.00 thousand USD worth of non-current assets. The company amassed the most assets last year, totalling up to 2.60 million USD.

Wize Pharma, Inc. Income Statement

Name [in Millions USD]2009201020112012201320142015201620172018Trends
Research and development 0.001.830.000.720.810.200.450.69
Operating Expenses 0.000.000.00-1.151.390.63
Operating Income (Loss) -1.03-1.48-3.63
Interest expense 0.020.02
Other Nonoperating Income (Expense) -0.09-0.29
Income Tax Expense (Benefit)
Net income -0.000.000.00-1.20-1.48-0.92-2.97-3.28

Wize Pharma, Inc. Balance Sheet

Name [in Millions USD]2009201020112012201320142015201620172018Trends
Cash and cash equivalents 001.940.850.150.010.030.020.431.80
Available-for-sale Securities, Current 0.170.58
Accounts Receivable, Net, Current 00
Deferred income taxes -1.31-1.76-2.59-2.741.702.24
Available-for-sale Securities, Noncurrent 1.340.13
Total assets 00.000.001.000.700.640.410.692.60
Current assets 00.000.001.000.700.660.410.682.54
Non-current assets 0.000.000.000.000.000.06
Accounts payable 0.000.010.000.00
Total current liabilities 0.120.001.042.063.204.285.002.962.10
Total liabilities 0.120.090.252.19
Common Stock, Value, Issued 0.010.000.010.010.010.010.010.010.01
Retained Earnings (Accumulated Deficit) -0.25-0.00-5.14-6.64-7.82-9.07-10.12-27.40-31.89
Accumulated Other Comprehensive Income (Loss), Net of Tax -0.00-0.000.010.11-0.19-0.10-0.07-0.07

Wize Pharma, Inc. Cash Flow

Name [in Millions USD]2009201020112012201320142015201620172018Trends
Net income -0.000.000.00-1.20-1.48-0.92-2.97-3.28
Depreciation 00.000.000.000.00
Accounts receivable -0.00
Net Cash Provided by (Used in) Operating Activities -0.00-0.00-0.81-0.410.03-0.87-1.36-2.21
Payments to Acquire Property, Plant, and Equipment 0.000.000.000.000.01
Net Cash Provided by (Used in) Investing Activities 00.51-0.00-0.000.25
Stock Issued During Period, Value, Share-based Compensation, Net of Forfeitures 0.00
Stock Issued During Period, Value, Share-based Compensation, Net of Forfeitures 0.00
Proceeds from Issuance of Common Stock 0.00000.02
Net Cash Provided by (Used in) Financing Activities 0.0000.471.544.91
Cash and Cash Equivalents, Period Increase (Decrease) 0.00-2.71-0.31-0.410.03-0.400.19